Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening

Gynecol Oncol. 2003 Jan;88(1 Pt 2):S152-7. doi: 10.1006/gyno.2002.6708.
No abstract available

Publication types

  • Review

MeSH terms

  • CA-125 Antigen / biosynthesis
  • CA-125 Antigen / blood*
  • CA-125 Antigen / chemistry
  • CA-125 Antigen / genetics
  • Female
  • Forecasting
  • Humans
  • Mass Screening / methods
  • Ovarian Neoplasms / blood*

Substances

  • CA-125 Antigen